Pulmonx Corporation · NASDAQ:LUNG
French Glendon E. III sold 56,149 Pulmonx Corporation shares (Form 4)
Traded Jun 1 to Jun 2, 2026 · Filed Jun 3, 2026
From Jun 1 to Jun 2, 2026, French Glendon E. III (Director, President and CEO) sold 56,149 Pulmonx Corporation shares at an average US$1.55 for US$86,875, leaving 1,178,162 shares. Filed Jun 3, 2026 (Form 4).
- Sold
- 56,149 shares
- Price
- US$1.55 average (US$1.54 to US$1.57)
- Value
- US$86,875
- Holding after
- 1,178,162 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Sale | 4,171 | US$1.54 | 1,230,140 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 38,467 | US$1.54 | 1,191,673 | Direct |
| Jun 2, 2026 | Common Stock | Sale | 13,511 | US$1.57 | 1,178,162 | Direct |
Source
Related
- Pulmonx Corporation
- French Glendon E. III
- Pulmonx Corporation shareholders
- Form 4 · French Glendon E. III · Sep 3, 2026
- Form 4 · Radhakrishnan Srikanth · Sep 3, 2026
- Form 4 · Lehman David Aaron · Sep 3, 2026
- Form 4 · Rose Geoffrey Beran · Sep 3, 2026
- Schedule 13G/A · Morgan Stanley · Aug 13, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026